Search
MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.
A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
The insights lay the groundwork for earlier diagnosis and better treatment of the disease.
Learn how tiny sensors made of nanotubes could serve as implantable devices that offer a noninvasive way to monitor cancer and its treatments.
Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.
One size does not fit all when it comes to treating renal cell carcinoma.
MSK investigators find that the presence of certain gene mutations in patients’ blood may mean they are more likely to get a secondary leukemia.